scorecardresearch
Add as a preferred source on Google
Wednesday, August 5, 2026
TopicGLP 1 drugs

Topic: GLP 1 drugs

New weight loss drug delivers extraordinary results in late-stage obesity. Clears Phase 3 trial

Retatrutide by Eli Lilly is a once-weekly medicine that can lower food intake, improve glucose control, and increase calorie burning.

GLP-1 drugs cut sick days by half. Researchers now think it could save healthcare systems billions

A UK study has found that people taking Ozempic and Wegovy took fewer sick days and needed fewer hospital visits

As GLP-1 generics flood Indian market, drug regulator cracks down on illegal sale & misleading ads

The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.

On Camera

Operation Sindoor to Epic Fury, air power is becoming war’s opening move

Air power used to be the instrument of escalation, the thing a state reached for once diplomacy had failed. Increasingly, it is no longer the last resort.

Life insurance policy surrender, withdrawal payouts jump to Rs 2.8 lakh-crore, exceed maturity benefits

Govt says surrender & withdrawal payouts accounted for 39% of total benefits in 25-26, up from 32% in 21-22, driven by affordability issues, mis-selling, changing financial circumstance.

‘When Pakistan sought ceasefire, we kept it waiting’—Gen Anil Chauhan reveals India’s Op Sindoor flex

Pakistan reached out to India around 9.30 am on 10 May 2025 but Indian DGMO spoke only in the afternoon, just retired Chief of Defence Staff Anil Chauhan says at ThePrint's Off The Cuff.

Modi govt response to Gen Z protest shows a rare vulnerability. It’s an opportunity for Opposition

The young people broke the self-imposed silence among the elite not to speak a word critical of the Modi government, except to whisper on the sidelines, looking left, right and behind.